Delaware-based Med Dev has obtained $775,000 in private financing and hopes to raise $2.225 million more. The startup will use the money to conduct further research and pursue FDA approval for its devices, which are intended to help eliminate nasal methicillin-resistant Staphylococcus aureus colonization without the need for antibiotics.
Del. startup gets $775k boost for nasal MRSA devices
SmartBrief Job Listings for Health Care
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|
|Director Account Management||
Samaritan Health Services
|Hospital Medical Device Sales||
Linda Hertz Group